Prices are updated after-hours


Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date

crawled time : 15:00    save search

Jazz Pharmaceuticals to Present Long-Term and Real-World Data Emphasizing Commitment to Treatment-Resistant Epilepsy at the 2023 American Epilepsy Society Annual Meeting
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
JAZZ | $119.11 0.74% 0.0% 640K twitter stocktwits trandingview |
Health Technology
| | O: -0.66% H: 0.0% C: 0.0%

pharmaceuticals meeting
GeneDx Presents New Data at the American Epilepsy Society Annual Meeting Demonstrating That Exome Sequencing Outperforms Multi-Gene Panels for Patients with Epilepsy
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
WGS | $1.8 2.86% 2.78% 280K twitter stocktwits trandingview |
Professional, Scientific, and T...
| | O: -0.57% H: 0.0% C: 0.0%

meeting
Intensity Therapeutics Selected for Spotlight Oral Presentation at the 2023 San Antonio Breast Cancer Symposium
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
INTS | $3.15 28.55% 17.35% 22K twitter stocktwits trandingview |
| | O: 8.61% H: 0.0% C: 0.0%

breast symposium presentation cancer therapeutics
Ovid Therapeutics to Present Five Abstracts Supporting its Epilepsy Programs at the 77th American Epilepsy Society Annual Meeting (2023)
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
OVID | $3.195 7.4% 7.03% 110K twitter stocktwits trandingview |
Health Technology
| | O: 3.53% H: 0.0% C: 0.0%

meeting therapeutics
Palvella Therapeutics and Ligand Pharmaceuticals Expand Strategic Partnership to Accelerate Phase 3 Development of QTORIN™ rapamycin for Microcystic Lymphatic Malformations and Additional High Unmet Need Clinical Indications
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
LGND | $58.75 0.76% 2.3% 74K twitter stocktwits trandingview |
Health Technology
| | O: 0.36% H: 0.0% C: 0.0%

partnership pharmaceuticals therapeutics
Allogene Therapeutics Announces Participation in December Investor Conference
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
ALLO | $2.52 7.23% 0.0% 2.4M twitter stocktwits trandingview |
Health Technology
| | O: 3.95% H: 0.0% C: 0.0%

conference therapeutics
Neurona Therapeutics Presents New Clinical Data from First Cohort in Ongoing Phase I/II Open-Label Trial of NRTX-1001 Cell Therapy for Drug-resistant Mesial Temporal Lobe Epilepsy (MTLE)
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
TOT | $48.3 0% twitter stocktwits trandingview |
Energy Minerals
| Email alert Add to watchlist

nrtx-1001 cell ongoing trial therapeutics therapy
MUSIC BIZ WORLDWIDE: ‘SPINNIN’ RECORDS HAS AN INDEPENDENT APPROACH, BUT WITH MAJOR OPPORTUNITIES ON BOTH A LOCAL AND WORLDWIDE LEVEL.
Published: 2023-12-01 (Crawled : 15:00) - wmg.com
FNCTF | $12.36 0.08% -26.03% 1K twitter stocktwits trandingview |
Communications
| Email alert Add to watchlist

worldwide
300 PUBLISHING SIGNEE SEAN MOMBERGER SCORES BILLBOARD HOT 100 NO. 1 WITH JACK HARLOW’S “LOVIN ON ME”
Published: 2023-12-01 (Crawled : 15:00) - wmg.com
FNCTF | $12.36 0.08% -26.03% 1K twitter stocktwits trandingview |
Communications
| Email alert Add to watchlist

jack 100 hot
VARIETY: YNG LVCAS, PESO PLUMA AND MORE TALK EVOLUTION OF ‘LA BEBE’: ‘COULDN’T HAVE COME AT A BETTER TIME
Published: 2023-12-01 (Crawled : 15:00) - wmg.com
FNCTF | $12.36 0.08% -26.03% 1K twitter stocktwits trandingview |
Communications
| Email alert Add to watchlist


NeuroPace and the RNS System Showcased at the 77th American Epilepsy Society (AES) Annual Meeting
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
NPCE S | $8.9 -1.0% -1.35% 30K twitter stocktwits trandingview |
Manufacturing
| | O: 0.51% H: 0.0% C: 0.0%

system meeting
Gain Therapeutics Announces Preclinical Data Showing Restoration of Enzymatic Function with Novel Allosteric Regulators in GM1 Gangliosidosis Model
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
GANX | $2.2 2.8% 10.32% 53K twitter stocktwits trandingview |
Professional, Scientific, and T...
| Email alert Add to watchlist

preclinical therapeutics
Navidea Biopharmaceuticals, Inc. and Capital Royalty Partners II, L.P. Enter Binding Settlement Agreement and Mutual Release
Published: 2023-12-01 (Crawled : 15:00) - biospace.com/
NAVB | $0.0699 39.52% -43.49% 680K twitter stocktwits trandingview |
Health Technology
| Email alert Add to watchlist

royalty agreement
Cyclacel Regains Compliance With Nasdaq Listing Rule Following Filing of Its Form 10-Q With the SEC
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
CYCC | $0.2699 -10.03% 6.11% 450K twitter stocktwits trandingview |
Health Technology
| | O: 11.87% H: 19.9% C: -10.07%

nasdaq
Teva Completes Closing of Exclusive Collaboration Deal to Deliver Inflammatory Bowel Disease Treatment
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
SNYNF | $94.0 1.34% 1.34% 860 twitter stocktwits trandingview |
Health Technology
| | O: -0.35% H: 0.0% C: 0.0%
TEVA | $9.71 -1.12% 0.0% 6.2M twitter stocktwits trandingview |
Health Technology
| | O: -0.52% H: 3.73% C: 1.87%
SNY | $46.72 -0.06% -0.06% 1.1M twitter stocktwits trandingview |
Health Technology
| | O: -1.09% H: 0.0% C: 0.0%

disease treatment collaboration teva deal
Protara Therapeutics Announces Presentation of Additional Encouraging Data from Phase 1a ADVANCED-1 Trial of TARA-002 in NMIBC at the 24th Annual Meeting of the Society of Urologic Oncology
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
TARA | $1.435 -1.03% -1.05% 20K twitter stocktwits trandingview |
Health Technology
| | O: -2.01% H: 4.71% C: -0.68%

tara-002 presentation meeting trial therapeutics
Guardant Health to present data at San Antonio Breast Cancer Symposium demonstrating utility of liquid biopsy in biomarker identification, therapy selection and residual disease detection
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
GH | $26.33 4.61% 0.61% 1.1M twitter stocktwits trandingview |
Health Services
| | O: 1.51% H: 3.92% C: -1.29%

disease breast health symposium biomarker cancer therapy
urban-gro, Inc. Awarded $9.6 Million Industrial Design-Build Contract with Existing CPG Client
Published: 2023-11-30 (Crawled : 15:00) - globenewswire.com
UGRO | $1.18 4.43% -2.26% 97K twitter stocktwits trandingview |
| | O: 5.17% H: 1.64% C: -7.38%

contract
Gilead’s Leadership in Metastatic Breast Cancer Showcased With New Trodelvy Data at San Antonio Breast Cancer Symposium 2023
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
GILD | $77.65 1.37% -0.05% 5.4M twitter stocktwits trandingview |
Health Technology
| | O: 0.2% H: 1.8% C: 1.62%

trodelvy breast symposium cancer
Ocuphire Pharma Announces Presentation at Ophthalmology Innovation Summit (OIS) XIIIInvestor Call with CEO, George Magrath, M.D., M.B.A., M.S. on December 5, 2023
Published: 2023-11-30 (Crawled : 15:00) - biospace.com/
OCUP A | $2.99 -1.97% -2.18% 290K twitter stocktwits trandingview |
Health Technology
| | O: 3.28% H: 8.48% C: 7.77%

pharma presentation innovation
Gainers vs Losers
77% 23%

Top 10 Gainers
ID 4 | $0.077 -9.41% 25.97% 420K twitter stocktwits trandingview |
Finance

BKKT 4 | $1.88 25.33% 14.89% 4.8M twitter stocktwits trandingview |

MGLD | $1.03 7.77% 14K twitter stocktwits trandingview |
Manufacturing

CZOO | $0.4316 -6.52% 6.7% 65K twitter stocktwits trandingview |

SATX | $0.4226 -1.72% 6.48% 29K twitter stocktwits trandingview |
n/a

CCJ | $45.4 -1.13% 4.6% 3.9M twitter stocktwits trandingview |
Non-Energy Minerals

AUMN | $0.562 0.34% 4.5% 360K twitter stocktwits trandingview |
Non-Energy Minerals

ERJ | $18.69 6.86% 4.33% 2.9M twitter stocktwits trandingview |
Electronic Technology

JBL | $116.91 1.38% 4.3% 2M twitter stocktwits trandingview |
Electronic Technology

SAIC 4 | $119.92 2.14% 4.24% 460K twitter stocktwits trandingview |
Technology Services


Your saved searches
Save your searches and get alerts when important news are released.